ARCHIVES

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990

NCAB Meeting Moved To October

July 20, 1979

Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says

March 21, 1997

Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal

March 18, 1988

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011

Cooney to Oversee University of Michigan Clinical Operations

February 7, 2013